恶性血液病患者侵袭性真菌病防治策略被引量：3

Control strategies for invasive fungal disease in patients with hematologic malignancies

导出

摘要侵袭性真菌病（invasive fungal disease，IFD）是恶性血液病患者的常见感染并发症。随着现代恶性血液病治疗手段的发展，IFD的发病率呈上升趋势，严重威胁患者生命。由于诸多因素的限制，多数患者难以获得确诊IFD，且其临床表现无特异性，实验室检查也受灵敏度和特异性的限制，CT扫描受检查频度及人为因素的限制，IFD也常常延误早期诊断。本文对恶性血液病患者IFD的防治策略进行概述。

作者冯四洲何祎

机构地区中国医学科学院北京协和医学院血液学研究所血液病医院

出处《临床血液学杂志》 CAS 2015年第2期194-197,共4页 Journal of Clinical Hematology

基金天津市应用基础与前沿技术研究计划(No:14JCZDJC33000) 卫生部卫生行业科研专项(No:201202017) 国家科技支撑项目(No:2013BAIO1BO9)

关键词血液病恶性侵袭性真菌病 hematologic malignancies invasive fungal disease

分类号 R733 [医药卫生—肿瘤]

引文网络
相关文献

参考文献17

1Zhang P,Jiang EL,Yang DL,et al.Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients:a single-institution experience[J].Transpl Infect Dis,2010,12:316-321.
2Pagano L,Caira M,Candoni A,et al.The epidemiology of fungal infections in patients with hematologic malignancies:the SEIFEM-2004study[J].Haematologica,2006,91:1068-1075.
3Kurosawa M,Yonezumi M,Hashino S,et al.Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies[J].Int J Hematol,2012,96:748-757.
4Li Y,Xu W,Jiang Z,et al.Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy:a multicenter,prospective,non-interventional study in China[J].Tumor Biol,2014,35:5869-5876.
5Tacke D,Buchheidt D,Karthaus M,et al.Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies.2014update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology[J].Ann Hematol,2014,93:1449-1456.
6Girmenia C,Barosi G,Piciocchi A,et al.Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation:revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo(GITMO)[J].Biol Blood Marrow Transplant,2014,20:1080-1088.
7Cornely OA,Maertens J,Winston DJ,et al.Posaconazole vs.fluconazole or itraconazole prophylaxis in patients with neutropenia[J].N Engl J Med,2007,356:348-359.
8Ullmann AJ,Lipton JH,Vesole DH,et al.Posaconazole or fluconazole for prophylaxis in severe graftversus-host disease[J].N Engl J Med,2007,356:335-347.
9Pechlivanoglou P,Le HH,Daenen S,et al.Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies:a systematic review[J].J Antimicrob Chemother,2014,69:1-11.
10Vehreschild MJ,von Bergwelt-Baildon M,Tran L,et al.Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation:a 6-yr analysis from the cologne cohort for neutropenic patients[J].Eur J Haematol,2014,93:400-406.